NCT00583076View on ClinicalTrials.gov

Safety and Efficacy of AST-120 in the Treatment of Pouchitis

PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

May 31, 2008

Conditions

Pouchitis

Interventions

DRUG

AST-120

AST-120, 2grams,three times daily for 4 weeks. Responders in the second cohort of patients are eligible to receive AST-120 for up to 52 weeks.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Lead Sponsor

Ocera Therapeutics

All Listed Sponsors

lead

Ocera Therapeutics

INDUSTRY

NCT00583076 - Safety and Efficacy of AST-120 in the Treatment of Pouchitis | Biotech Hunter | Biotech Hunter